SUBSCRIBE
SUBSCRIBE

John Stanford

Pictured: Gavel hitting pill bottles with abstract money background
Drug Delivery
The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That.
Many promising small molecules have lost significant investment appeal as a result of lopsided incentives favoring biologics in 2022’s Inflation Reduction Act.
April 9, 2024
 · 
4 min read
 · 
John Stanford